Table 4.
References Talking About the Prognostic Factors
| References | Published Year | Population | Year of Case Collection | Case Number | Stage Systm | Stage | Treatment | Prognostic Factor Discussed | Measurement Methods |
|---|---|---|---|---|---|---|---|---|---|
| Toita et al.3 | 1995 | Japan | 1985–1991 | 70 | FIGO | IIB-IIIB | RT | Cervical diameter > 6 cm | CT |
| Polterauer et al.17 | 2012 | Austria | 1996–2009 | 528 | FIGO | IA1-IVB | S, RT, CT | Tumor size>2cm | Not mentioned |
| Wang et al19 | 2015 | China | 2005–2008 | 284 | FIGO | IA-IIIB | S, RT | Tumor size>4cm | Not mentioned |
| Kobierski, J. et al.4 | 2002 | Poland | NA | 499 | FIGO | I-IIA | S | Lymph node metastasis | Surgical pathology |
| Bae, H.S. et al.22 | 2016 | Korea | 2001–2010 | 397 | FIGO | IB2-IVA | CRT | Lymph node metastasis | MRI |
| Kim et al.23 | 2020 | Korea | 2000–2014 | 897 | FIGO | IB-IIA | S+adjuvant CRT | Lymph node metastasis | Surgical pathology |
| Chen et al.24 | 2020 | America | 2010–2015 | 19,377 | TNM | NA | S | Lymph node metastasis | Surgical pathology |
| China | 2008–2018 | 14 | FIGO | IB1-IIA2 | S | ||||
| Kilic et al.25 | 2021 | Turkey | 1993–2019 | 197 | FIGO 2009 | IB1–IIIB | S, RT, CCRT | Lymph node metastasis | Surgical pathology/imaging |
| Grigsby et al.26 | 2020 | America | 1997–2019 | 1282 | FIGO 2009 | I-IV | NA | Stage | PET |
| Brodeur et al.8 | 2021 | Canada | 2010–2018 | 216 | FIGO 2009 | IA1-IVA | RT, CRT | Stage | MRI and CT/PET. |
| Gurram et al.27 | 2020 | India | 2010–2016 | 118 | FIGO 2009 | IIIA, IIIB | RT, CRT | LTI | NA |
| Katanyoo et al.28 | 2017 | Thailand | 1995–2012 | 216 | FIGO | IIIB | RT, CCRT | LTI | Pelvic examination |
| Fang et al.29 | 2021 | China | 2007–2014 | 622 | FIGO 2009 | IIIB | RT, CRT | LTI | NA |
Abbreviations: FIGO, International Federation of Gynecology and Obstetrics; S, surgery; RT, radiotherapy; CT, chemotherapy; CT, computerized tomography; CRT, chemoradiation; MRI, magnetic resonance imaging; CCRT, concurrent chemoradiotherapy; NA, not available; PET, positron emission tomography; LTI, lower third of vaginal invasion.